NYSE: GLP
GLOBAL PARTNERS LPCIK 0001323468 · SIC 5171 · Petroleum & Petroleum Products
Mega
Revenue $18.6B
Assets $4.0B
as of Oct 18, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (CMTL 10-K) is open in full — no account needed.
8-K
Filed Oct 16, 2026
· Period ending Oct 16, 2026
Summary not yet generated.
10-Q
Filed Aug 7, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
Partner
Trade GLP commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Aug 7, 2026
· Period ending Aug 7, 2026
Summary not yet generated.
8-K
Filed Jul 30, 2026
· Period ending Jul 30, 2026
Summary not yet generated.
10-Q
Filed May 8, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
10-K
Filed Feb 27, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-K
Filed Feb 28, 2025
· Period ending Dec 31, 2024
Summary not yet generated.
424B5
Filed Mar 19, 2021
Summary not yet generated.
424B3
Filed Mar 17, 2021
Summary not yet generated.
424B3
Filed Dec 29, 2020
Summary not yet generated.
424B3
Filed Jan 10, 2020
Summary not yet generated.
424B5
Filed Aug 2, 2018
Summary not yet generated.
424B5
Filed May 15, 2017
Summary not yet generated.
10-Q/A
Filed Mar 31, 2014
· Period ending Sep 30, 2013
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 7, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Operations (Unaudited)
(In thousands, except per unit data)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Sales | 6,792,088 | 4,626,925 | 12,113,888 | 9,219,122 |
| Cost of sales | 6,463,147 | 4,354,563 | 11,452,780 | 8,691,519 |
| Gross profit | 328,941 | 272,362 | 661,108 | 527,603 |
| Costs and operating expenses: | ||||
| Selling, general and administrative expenses | 83,031 | 74,775 | 182,381 | 148,492 |
| Operating expenses | 136,834 | 135,663 | 266,068 | 262,378 |
| Amortization expense | 1,269 | 1,376 | 2,539 | 2,788 |
| Net loss (gain) on sale and disposition of assets | 444 | 271 | (2,982) | (2,219) |
| Long-lived asset impairment | — | 211 | — | 211 |
| Total costs and operating expenses | 221,578 | 212,296 | 448,006 | 411,650 |
| Operating income | 107,363 | 60,066 | 213,102 | 115,953 |
| Other income (expense): | ||||
| Income from equity method investments | 1,983 | 2,350 | 2,722 | 2,416 |
| Interest expense | (33,084) | (34,523) | (68,587) | (70,562) |
| Loss on early extinguishment of debt | — | (2,795) | — | (2,795) |
| Income before income tax expense (benefit) | 76,262 | 25,098 | 147,237 | 45,012 |
| Income tax (expense) benefit | (5,277) | 112 | (6,116) | (1,118) |
| Net income | 70,985 | 25,210 | 141,121 | 43,894 |
| Less: General partner’s interest in net income, including incentive distribution rights | 5,876 | 4,615 | 11,269 | 9,027 |
| Less: Preferred limited partner interest in net income | 1,781 | 1,781 | 3,562 | 3,562 |
| Net income attributable to common limited partners | 63,328 | 18,814 | 126,290 | 31,305 |
| Basic net income per common limited partner unit | 1.87 | 0.55 | 3.72 | 0.92 |
| Diluted net income per common limited partner unit | 1.86 | 0.55 | 3.70 | 0.92 |
| Basic weighted average common limited partner units outstanding | 33,928 | 33,918 | 33,909 | 33,902 |
| Diluted weighted average common limited partner units outstanding | 34,117 | 34,095 | 34,152 | 34,204 |
Consolidated Balance Sheets (Unaudited)
(In thousands, except unit data)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 23,913 | 12,243 |
| Accounts receivable, net | 706,324 | 530,142 |
| Accounts receivable-affiliates | 3,539 | 2,627 |
| Inventories | 577,826 | 549,118 |
| Brokerage margin deposits | 18,337 | 17,804 |
| Derivative assets | 10,960 | 17,067 |
| Prepaid expenses and other current assets | 85,126 | 98,486 |
| Total current assets | 1,426,025 | 1,227,487 |
| Property and equipment, net | 1,651,936 | 1,657,444 |
| Right of use assets, net | 361,390 | 378,358 |
| Intangible assets, net | 10,811 | 13,350 |
| Goodwill | 421,913 | 421,913 |
| Equity method investments | 117,415 | 113,755 |
| Other assets | 32,061 | 38,410 |
| Total assets | 4,021,551 | 3,850,717 |
| Liabilities and partners’ equity | ||
| Current liabilities: | ||
| Accounts payable | 714,317 | 573,202 |
| Working capital revolving credit facility-current portion | 74,600 | 126,100 |
| Lease liability-current portion | 72,065 | 73,775 |
| Environmental liabilities-current portion | 7,443 | 7,193 |
| Trustee taxes payable | 78,695 | 83,801 |
| Accrued expenses and other current liabilities | 204,693 | 207,580 |
| Derivative liabilities | 43,895 | 4,540 |
| Total current liabilities | 1,195,708 | 1,076,191 |
| Working capital revolving credit facility-less current portion | 100,000 | 100,000 |
| Revolving credit facility | 103,500 | 103,500 |
| Senior notes | 1,234,197 | 1,232,723 |
| Lease liability-less current portion | 297,846 | 311,429 |
| Environmental liabilities-less current portion | 85,966 | 88,772 |
| Financing obligations | 125,807 | 128,505 |
| Deferred tax liabilities | 67,657 | 64,534 |
| Other long-term liabilities | 62,303 | 69,520 |
| Total liabilities | 3,272,984 | 3,175,174 |
| Partners’ equity | ||
| Series B preferred limited partners (3,000,000 units issued and outstanding at June 30, 2026 and December 31, 2025) | 72,305 | 72,305 |
| Common limited partners (33,995,563 units issued and 33,848,979 outstanding at June 30, 2026 and 33,995,563 units issued and 33,765,290 outstanding at December 31, 2025) | 671,521 | 599,662 |
| General partner interest (0.67% interest with 230,303 equivalent units outstanding at June 30, 2026 and December 31, 2025) | 4,741 | 3,576 |
| Total partners’ equity | 748,567 | 675,543 |
| Total liabilities and partners’ equity | 4,021,551 | 3,850,717 |
Consolidated Statements of Cash Flows (Unaudited)
(In thousands)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Net income | 141,121 | 43,894 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 72,232 | 72,029 |
| Amortization of deferred financing fees | 3,953 | 3,658 |
| Bad debt expense | 1,068 | 794 |
| Unit-based compensation expense | 13,133 | 6,779 |
| Net gain on sale and disposition of assets | (2,982) | (2,219) |
| Long-lived asset impairment | — | 211 |
| Income from equity method investments | (2,722) | (2,416) |
| Dividends received on equity method investments | 487 | — |
| Loss on early extinguishment of debt | — | 2,795 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (177,250) | (92,167) |
| Accounts receivable-affiliate | (912) | (882) |
| Inventories | (28,919) | 98,148 |
| Broker margin deposits | (533) | (3,744) |
| Prepaid expenses, all other current assets and other assets | 12,555 | (3,167) |
| Accounts payable | 141,115 | 80,377 |
| Trustee taxes payable | (5,106) | 16,663 |
| Change in derivatives | 45,462 | 3,354 |
| Accrued expenses, all other current liabilities and other long-term liabilities | (7,980) | (59,377) |
| Net cash provided by operating activities | 204,722 | 164,730 |
| Cash flows from investing activities | ||
| Equity method investments | (7,057) | (20,271) |
| Capital expenditures | (66,848) | (32,953) |
| Seller note issuances, net | 3,233 | 142 |
| Dividends received of equity method investments | 5,631 | 4,676 |
| Proceeds from sale of property and equipment, net | 5,767 | 3,971 |
| Net cash used in investing activities | (59,274) | (44,435) |
| Cash flows from financing activities | ||
| Net payments on working capital revolving credit facility | (51,500) | (31,000) |
| Net payments on revolving credit facility | — | (78,800) |
| Proceeds from senior notes, net | — | 441,377 |
| Repayment of senior notes | — | (360,316) |
| Repurchase of common units | (6,043) | (3,557) |
| LTIP units withheld for tax obligations | (7,596) | (13,439) |
| Distribution equivalent rights | (3,262) | (4,017) |
| Distributions to limited partners and general partner | (65,377) | (62,654) |
| Net cash used in financing activities | (133,778) | (112,406) |
| Cash and cash equivalents | ||
| Increase in cash and cash equivalents | 11,670 | 7,889 |
| Cash and cash equivalents at beginning of period | 12,243 | 8,208 |
| Cash and cash equivalents at end of period | 23,913 | 16,097 |
| Supplemental information | ||
| Cash paid during the period for interest | 58,672 | 70,474 |
Amounts as printed on the EDGAR/iXBRL face — (In thousands, except per unit data); (In thousands, except unit data); (In thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗